Skip to content

Liquidia Corp

LQDA

CIK 0001819576 · Pharmaceutical Preparations · Nasdaq

← back to feed
Revenue (TTM)
$199.16M
+1,031.2% YoY Q1 May 2026
Net Income (TTM)
−$30.62M
+46.3% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.46
+50.9% YoY Q1 May 2026
Gross Margin
97.0%
Q1 May 2026
Operating Margin
-4.8%
Q1 May 2026
Net Margin
-15.4%
Q1 May 2026
Free Cash Flow (TTM)
−$15.16M
Q1 May 2026
Cash
$222.79M
Q1 May 2026
Total Debt
$19.88M
Q1 May 2026
Shares Outstanding
88.93M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings